Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIP for Hypoglycemia Prevention in Type 1 Diabetes
NCT03734718Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Jun 2019
- Primary completion
- Dec 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of glucose-dependent insulinotropic polypeptide[1-42] in type 1 diabetes mellitus (T1D) and hypoglycemia, sponsored by Steno Diabetes Center Copenhagen. Primary endpoint: Blood glucose at 6 days. Started Jun 2019; status: completed.
02
Drugs
glucose-dependent insulinotropic polypeptide[1-42]
03
Conditions
type 1 diabetes mellitus (T1D)hypoglycemia
Beyond the preview
Go deeper on NCT03734718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03734718.